Latest Blog Posts Tagged "Carbidopa-levodopa (Sinemet)"
December 08, 2016
Voyager Therapeutics announced results from a trial, supported in early stages by MJFF, to help the brain convert levodopa to dopamine and better control motor symptoms.
December 28, 2015
Adamas has announced positive Phase III results for its treatment for dyskinesia, involuntary movements that are a side effect of levodopa use. Such a therapy could impact how we treat motor symptoms.
May 06, 2015
Dr. Rachel Dolhun tells Practical Neurology about recently approved levodopa formulations that may help avoid wearing off and dyskinesia.
March 29, 2015
Rytary, an extended-release formuation of levodopa/carbidopa, will soon be available for prescription. The treatment requires more pills but comes with less dyskinesia.
January 12, 2015
Today pharmaceutical company AbbVie announced it has obtained approval for Duopa, its gel formulation of levodopa/carbidopa infused directly into the small intestine.
January 08, 2015
Today MJFF-awardee Impax Pharmaceuticals announced that the FDA approved RYTARY, an extended-release oral capsule formulation of levodopa-carbidopa, for the treatment of Parkinson's.
December 30, 2014
A belt-worn pump that delivers levodopa/carbidopa continuously under the skin may help alleviate the motor fluctuations associated with traditional, oral therapy.
December 15, 2014
In our latest podcast. MJFF CEO Dr. Todd Sherer discusses the progress in Parkinson's research seen this year.
October 30, 2014
The FDA has approved Israeli company Intec Pharma Ltd. to carry out a Phase III trial of the Accordion Pill for treatment of Parkinson's. The study is expected to begin in the second half of 2015.
October 24, 2014
Researchers call for a higher FDA advisory for dopamine agonist medications, commonly prescribed for Parkinson's disease, because of a strong link to impulse control disorders.